Abstract: A lower jaw thrusting (LJT) mandibular protracting oral airway device including an elongate member with a distal end and a proximal end defining an air passageway channel. The elongate member includes a lip flange, a curved main body, and a bite block. The lip flange is located at the proximal end and has an outwardly projecting surface. The curved main body extends to the distal end. The bite block is disposed between the lip flange and the curved main body. The bite block includes an upper dorsal surface having a first bite portion for maxillary incisor teeth engagement and a lower ventral surface having a second bite portion for mandibular incisor teeth engagement. The bite block includes a mandibular flange projecting downwards from the lower ventral surface located distal to the second bite portion for mandibular incisor teeth engagement and proximal to the first bite portion for maxillary incisor engagement.

Abstract: A lower jaw and tongue thrusting endotracheal tube and flexible fiberoptic endoscope intubation oral airway device having an elongated body including, a mandible flange with a lingual flat portion transversely disposed on a ventral surface of a tongue plate. The device having an open top toward the palate like a rectangular trough. The trough extends through the device from the proximal end to the front middle part of the tongue plate. The device includes an L-shaped insert that slideably couples between the upper lip flanges and acts also as dorsal surface of the bite block. The distal end of the tongue plate end comprises a curved surface which tapers to a narrow distal edge. A pair of upstanding walls attach to the tongue faceplate ventral surface edges which taper as they extend posteriorly. The walls ensure protection for medical instruments disposed within the flexible fiberoptic endoscope guide.

Abstract: A lower jaw thrusting (LJT) mandibular protracting oral airway device including an elongate member with a distal end and a proximal end defining an air passageway channel. The elongate member includes a lip flange, a curved main body, and a bite block. The lip flange is located at the proximal end and has an outwardly projecting surface. The curved main body extends to the distal end. The bite block is disposed between the lip flange and the curved main body. The bite block includes an upper dorsal surface having a first bite portion for maxillary incisor teeth engagement and a lower ventral surface having a second bite portion for mandibular incisor teeth engagement. The bite block includes a mandibular flange projecting downwards from the lower ventral surface located distal to the second bite portion for mandibular incisor teeth engagement and proximal to the first bite portion for maxillary incisor engagement.

Abstract: A Safe and effective treatment methods to cure and curtail tuberculosis affliction described using high dose Vitamin C, and other known anti-mycobacterium tuberculosis drugs especially rifampicin administered intravenously for 6 weeks instead of 6 to 24 months of conventional treatment. Insulin is administered to induce moderate hypoglycemia to augment and add effectiveness of anti-tuberculosis drugs and Vitamin C. Invention also delivers the drugs directly to a tuberculin lesion through a catheter. An embodiment of the invention uses a nebulizer and other methods of administration of Vitamin C with anti-tuberculosis drugs, interferon Y?, Coley's vaccine, dinitrophenol hyperthermia, ozone therapy, Hydrogen peroxide therapy and artemisinin, combined with oxygen supplementation including autohemotherapy with ozone, hyperbaric therapy, and hypertheramia to increase the respiration of the M. tuberculosis bacteria which has a killing effect.

Abstract: The present invention is a safe, inexpensive, easy to use and effective anti-snoring and anti-sleep apnea treatment device. The device has a vertical and horizontal bar. The horizontal bar is placed inside the mouth, behind or between the molar teeth with palatine and tongue shelves to prevent snoring and movement of the tongue backwards. The device is tethered to the hard palate by vacuum cups to prevent the movement of the tongue backwards during sleep to prevent sleep apnea. The proximal end of the vertical bar is anchored to string at the distal end with hook and loop fabric closure adhesive attachment and to the lips outside the mouth to prevent the accidental swallowing and aspiration of the device; and at the same time holds the tongue and device firmly in the mouth. The device is provided with canula with three way stopcocks to deliver supplemental oxygen and therapeutic agents.

Abstract: A device for snoring and obstructive sleep apnea treatment has an oral elastic glove portion adapted to removably cover a free moving portion of a user's tongue. Three vacuum suction cups are used to attach the device to the hard palate and the dorsal and ventral surfaces of the tongue in order to hold the device in place without allowing the tongue to move backwards. A vacuum creating cannula and a syringe attached to a tip of the device to create a vacuum once the device in positioned in the user's mouth. In addition, a balloon is provided to prevent soft palate vibrations. A skin attachment pad is removably attached to the user's face close to the mouth and holds the end of a string provided to secure the tongue glove from moving during sleep or be accidentally swallowed.

Abstract: This invention describes the administration of multiple therapeutic agents with insulin in conjunction with bexarotene, ketamine, monoclonal antibodies Etanercept, IGF-1, and acetylcholine esterase inhibitors physostigmine, for treatment of Alzheimer's disease and other neurodegenerative diseases. Insulin, improves memory; also augments and amplifies the effects of the adjuvant therapeutic agents (paracrine and intracrine effects) and consequently reduces the ? amyloid, its soluble precursors, prevents damage to the neuronal skeletal network (taupathy), and blocks glutamate excitotoxicity, reduces brain inflammation, prevents apoptosis, and increases the acetylcholine levels in the neurons and synapses; by using a combination of insulin, bexarotene, ketamine, Etanercept, IGF-1, and physostigmine therapeutic agents.

Abstract: This invention describes the administration of multiple therapeutic agents with insulin in conjunction with bexarotene, ketamine, monoclonal antibodies Etanercept, IGF-1, and acetylcholine esterase inhibitors physostigmine, for treatment of Alzheimer's disease and other neurodegenerative diseases. Insulin, improves memory; also augments and amplifies the effects of the adjuvant therapeutic agents (paracrine and intracrine effects) and consequently reduces the ? amyloid, its soluble precursors, prevents damage to the neuronal skeletal network (taupathy), and blocks glutamate excitotoxicity, reduces brain inflammation, prevents apoptosis, and increases the acetylcholine levels in the neurons and synapses; by using a combination of insulin, bexarotene, ketamine, Etanercept, IGF-1, and physostigmine therapeutic agents.

Abstract: An electric motor drive system capture and control apparatus for energy savings has an alternating current power source electrically connected to a direct current motor. A power rectifier diode rated for the alternating current power source and the direct current motor is electrically connected in a reverse bias mode between the negative supply wire of the direct current motor and a grounded neutral conductor of the alternating current power source. A ground wire is electrically connected to the direct current motor and cross connected to a hot lag wire of the alternating current power source. The direct current motor is voltage matched to the alternating current power source. A transformer is electrically connected to the alternating current power source and the direct current motor. The system may be scaled to work with a power grid or for use in a vehicle.

Abstract: An electric motor drive system capture and control apparatus for energy savings has an alternating current power source electrically connected to a direct current motor. A power rectifier diode rated for the alternating current power source and the direct current motor is electrically connected in a reverse bias mode between the negative supply wire of the direct current motor and a grounded neutral conductor of the alternating current power source. A ground wire is electrically connected to the direct current motor and cross connected to a hot lag wire of the alternating current power source. The direct current motor is voltage matched to the alternating current power source. A transformer is electrically connected to the alternating current power source and the direct current motor. The system may be scaled to work with a power grid or for use in a vehicle.

Abstract: A high efficiency light bulb has an outer globe with a base and a detachable bulb portion. The base has a base connection portion with a screw base and a control circuit with transformer for controlling and conveying electric power from the screw base to a quartz tungsten filament. The detachable bulb portion has an outer globe and an inner globe. At least the inner globe has a transparent infrared heat reflecting coating to improve efficiency by retaining heat within and reflecting the heat back on the filament. In another embodiment, the bulb and base are not detachable and the whole bulb is replaced when it reaches the end of its usefulness. A non-reactive gas such as krypton, bromine or xenon, for example, is used to fill the bulbs.

Abstract: This invention describes the administration of multiple therapeutic agents with insulin in conjunction with bexarotene, ketamine, monoclonal antibodies Etanercept, IGF-1, and acetylcholine esterase inhibitors physostigmine, for treatment of Alzheimer's disease and other neurodegenerative diseases. Insulin, improves memory; also augments and amplifies the effects of the adjuvant therapeutic agents (paracrine and intracrine effects) and consequently reduces the ? amyloid, its soluble precursors, prevents damage to the neuronal skeletal network (taupathy), and blocks glutamate excitotoxicity, reduces brain inflammation, prevents apoptosis, and increases the acetylcholine levels in the neurons and synapses; by using a combination of insulin, bexarotene, ketamine, Etanercept, IGF-1, and physostigmine therapeutic agents.

Abstract: This invention describes the administration of multiple therapeutic agents with insulin in conjunction with bexarotene, ketamine, monoclonal antibodies Etanercept, IGF-1, and acetylcholine esterase inhibitors physostigmine, for treatment of Alzheimer's disease and other neurodegenerative diseases. Insulin, improves memory; also augments and amplifies the effects of the adjuvant therapeutic agents (paracrine and intracrine effects) and consequently reduces the ? amyloid, its soluble precursors, prevents damage to the neuronal skeletal network (taupathy), and blocks glutamate excitotoxicity, reduces brain inflammation, prevents apoptosis, and increases the acetylcholine levels in the neurons and synapses; by using a combination of insulin, bexarotene, ketamine, Etanercept, IGF-1, and physostigmine therapeutic agents.

Abstract: A device for snoring and obstructive sleep apnea treatment has an oral elastic glove portion adapted to removably cover a free moving portion of a user's tongue. Three vacuum suction cups are used to attach the device to the hard palate and the dorsal and ventral surfaces of the tongue in order to hold the device in place without allowing the tongue to move backwards. A vacuum creating cannula and a syringe attached to a tip of the device to create a vacuum once the device in positioned in the user's mouth. In addition, a balloon is provided to prevent soft palate vibrations. A skin attachment pad is removably attached to the user's face close to the mouth and holds the end of a string provided to secure the tongue glove from moving during sleep or be accidentally swallowed.

Abstract: The present invention is a safe, inexpensive, easy to use and effective anti-snoring and anti-sleep apnea treatment device. The device has a vertical and horizontal bar. The horizontal bar is placed inside the mouth, behind or between the molar teeth with palatine and tongue shelves to prevent snoring and movement of the tongue backwards. The device is tethered to the hard palate by vacuum cups to prevent the movement of the tongue backwards during sleep to prevent sleep apnea. The proximal end of the vertical bar is anchored to string at the distal end with hook and loop fabric closure adhesive attachment and to the lips outside the mouth to prevent the accidental swallowing and aspiration of the device; and at the same time holds the tongue and device firmly in the mouth. The device is provided with canula with three way stopcocks to deliver supplemental oxygen and therapeutic agents.

Abstract: A anti-snoring and anti-obstructive sleep apnea apparatus has a plate or metal frame tongue shelf splint to prevent the flaccid tongue falling back, a palate shelf splint projection to elevate the soft palate and prevents its vibration, incisors teeth receptacles or pockets sockets for jaw displacer to hold the mandible moved forwards, and to prevent it falling back held between the bite block, catheter-tubing to administer oxygen supplementation from the external source which reduces air turbulence and promotes nasal breathing, a submental suprahyoid muscle stimulator placed below the tongue, and above the mucous membrane. An injection port is provided to administer any therapeutic agents and local anesthetics to reduce the sensitivity of the tongue and oral cavity mucus membrane lining to the foreign objects. This device is used to deliver therapeutic agents to prevent and to treat halitosis and various diseases.

Abstract: A therapeutic device and method for blocking pain in a patient's digit includes a ring-like vibratory element adapted to be fitted about the digit temporarily and controller coupled to the ring-like vibratory element for controlling its operation. By applying vibration to the patient's digit, pain transmission is blocked or lessened along the digit, allowing the patient or a caregiver to provide treatment to the digit with reduced pain, such as when a diabetic's finger is to be stuck for drawing blood for a blood sugar measurement). Moreover, if the digit is injured, the present invention can provide pain relief from the injury as well. Further, the invention can be applied to the digit in combination with other pain-reducing therapies, such as the application of ice, the application of topical analgesics, the application of local anesthetics, etc. The controller includes an on/off control switch and a switch for controlling the vibratory frequency.